Silk Road Medical nets $128mm in IPO

Silk Road Medical Inc. (stroke prevention devices used in minimally invasive transcarotid surgeries) netted $128mm in its initial public offering of 6.9mm shares (including the overallotment) at $20, the high end of its anticipated range. Three days prior to the final pricing, the company announced it planned to sell 4.7mm shares between $15-17, and then two days later upped the offering to 6mm shares between $19-20, before pricing at the high end of that range.